The outlook revision is based on a number of factors, including NMHS’ strong profitability and steady balance sheet.
Fitch also affirmed the “A-” rating on NMHS’ $223.2 million of series 2015 bonds.
More articles on healthcare finance:
William Harris Investors increases stake in CHS as share prices decline
5 hospital CFOs in the headlines
Simcoe Capital Management ups stake in LifePoint
